DFIN vs SRPT · P/E 20, rev $429.7M vs rev $1.13B
Donnelley Financial Solutions Inc (DFIN) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Donnelley Financial Solutions Inc (DFIN) is a software - application company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DFIN revenue for 2026-06-30 was $429.7M. Net income was $69.9M. DFIN currently screens at market cap $1.69B and trailing P/E 20.2.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
DFIN currently screens at market cap $1.69B and trailing P/E 20.2. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DFIN and SRPT stock pages for the full models.
Not investment advice.